Skip to main content

Table 2 Comparison of the main outcomes in women enrolled in IPTp-SP and ISTp-AL arms (at 36–40 weeks gestation and birth)

From: Intermittent screening and treatment with artemether–lumefantrine versus intermittent preventive treatment with sulfadoxine–pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria

Outcome

ATP analysis

mITT analysis

Control (IPTp-SP)

Intervention (ISTp-AL)

p-value

Control (IPTp-SP)

Intervention (ISTp-AL)

p-value

Severe anaemia (Hb < 8 g/dl)

2/114 (1.7)

0/124 (0)

0.133

2/115 (1.7)

0/124 (0)

0.142

Moderate anaemia (Hb 8–10.9 g/dl)

36/114 (31.6)

30/124 (24.2)

36/115 (31.3)

30/124 (24.2)

Hb ≥ 11 g/dl

76/114 (66.7)

94/124 (75.8)

77/115 (67)

94/124 (75.8)

Mean haemoglobin g/dl (SD)

11.4 (1.3)

11.7 (1.2)

0.073

11.4 (1.4)

11.7 (1.2)

0.076

Birth weight

 Normal (≥ 2.5 kg)

130/139 (93.5)

139/147 (94.6)

0.712

148/158 (93.7)

157/167 (94)

0.898

 Low (< 2.5 kg)

9/139 (6.5)

8/147 (5.4)

10/158 (6.3)

10/167 (6.0)

 Mean (SD)

3.21 (0.51)

3.18 (0.54)

0.062

3.21 (0.53)

3.17 (0.53)

0.497

 Median (IQR)

3.2 (0.6)

3.2 (0.6)

 

3.2 (0.6)

3.2 (0.6)

 

Parasitaemia

 Peripheral blood (light microscopy)

All infections

4/96 (4.2)

2/112 (1.8)

0.304

4/96 (4.2)

2/112 (1.8)

0.304